Dialysis stocks surge after California rejected a limit on dialysis clinic revenues in the midterm elections

Markets Insider
  • Dialysis stocks are up Wednesday following the midterm election.
  • The three big dialysis companies all received a bump.DaVita HealthCare is up 14%, American Renal Associates is up 4%, and Fresenius Medical is up 9%.
  • Healthy kidneys help the body filter out impurities from the blood, and dialysis helps replace that function for patients whose kidneys aren’t working properly.
  • The uptick in stocks in the industry is due to voter rejection of Proposition 8 in California.
  • The ballot measure would have limited a dialysis clinic’s revenue to 115% of the average cost of dialysis treatment in the state, according to analysts at Leerink.
  • If Proposition 8 had passed, DaVita, one of the largest providers of dialysis, would have lost $US450 million a year,California Healthline reported.

NOW WATCH: Money & Markets videos

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.